1 | BST2
|
| BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection.
|
| Urata S, Kenyon E, Nayak D, Cubitt B, Kurosaki Y, Yasuda J, de la Torre JC, McGavern DB.
|
| PLoS Pathog 14(7):e1007172. doi: 10.1371/journal.ppat.1007172. eCollection 2018 Jul.
2018
|
2 | BST2
|
| BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer.
|
| Liu W, Cao Y, Guan Y, Zheng C.
|
| Biotechnol Lett 40(7):1015-1027. doi: 10.1007/s10529-018-2562-z. Epub 2018 May 17.
2018
|
3 | BST2, DHX58, MAVS
|
| Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells.
|
| Jin S, Tian S, Luo M, Xie W, Liu T, Duan T, Wu Y, Cui J.
|
| Mol Cell 68(2):308-322.e4. doi: 10.1016/j.molcel.2017.09.005. Epub 2017 Sep 28.
2017
|
4 | BST2
|
| Bending of the BST-2 coiled-coil during viral budding.
|
| Ozcan KA, Berndsen CE.
|
| Proteins 85(11):2081-2087. doi: 10.1002/prot.25362. Epub 2017 Aug 12.
2017
|
5 | BST2, MARCHF8, NEDD4
|
| Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.
|
| Roy N, Pacini G, Berlioz-Torrent C, Janvier K.
|
| J Cell Sci 130(9):1596-1611. doi: 10.1242/jcs.195412. Epub 2017 Mar 20. 2017
|
6 | BST2, SGTA
|
| The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species.
|
| Waheed AA, MacDonald S, Khan M, Mounts M, Swiderski M, Xu Y, Ye Y, Freed EO.
|
| Sci Rep 6:24934. doi: 10.1038/srep24934.
2016
|
7 | BST2
|
| Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.
|
| Bego MG, Cong L, Mack K, Kirchhoff F, Cohen ÉA.
|
| J Virol 90(22):10236-10246. Print 2016 Nov 15.
2016
|
8 | AIFM1, BST2
|
| CD317 Promotes the survival of cancer cells through apoptosis-inducing factor.
|
| Li X, Zhang G, Chen Q, Lin Y, Li J, Ruan Q, Chen Y, Yu G, Wan X.
|
| J Exp Clin Cancer Res 35(1):117. doi: 10.1186/s13046-016-0391-2.
2016
|
9 | BST2, MMP14
|
| MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction.
|
| Fan L, Liu L, Zhu C, Zhu Q, Lu S, Liu P.
|
| Int J Mol Sci 17(6). pii: E818. doi: 10.3390/ijms17060818.
2016
|
10 | BST2
|
| Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge.
|
| Holmgren AM, Miller KD, Cavanaugh SE, Rall GF.
|
| J Virol 89(21):11011-8. doi: 10.1128/JVI.01745-15. Epub 2015 Aug 26.
2015
|
11 | BST2
|
| CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
|
| Gong S, Osei ES, Kaplan D, Chen YH, Meyerson H.
|
| Int J Clin Exp Pathol 8(2):1613-21. eCollection 2015.
2015
|
12 | BST2
|
| Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.
|
| Welbourn S, Kao S, Du Pont KE, Andrew AJ, Berndsen CE, Strebel K.
|
| J Biol Chem 290(6):3740-51. doi: 10.1074/jbc.M114.617639. Epub 2014 Dec 18.
2015
|
13 | BST2
|
| An unconventional BST-2 function: down-regulation of transient protein expression.
|
| Narkpuk J, Wanitchang A, Kramyu J, Frantz PN, Jongkaewwattana A, Teeravechyan S.
|
| Biochem Biophys Res Commun 450(4):1469-74. doi: 10.1016/j.bbrc.2014.07.022. Epub 2014 Jul 11.
2014
|
14 | BST2
|
| BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.
|
| Amet T, Byrd D, Hu N, Sun Q, Li F, Zhao Y, Hu S, Grantham A, Yu Q.
|
| Curr Mol Med 14(3):349-60.
2014
|
15 | BST2
|
| Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated BST-2/tetherin regulation.
|
| Jones PH, Okeoma CM.
|
| Cell Signal 25(12):2752-61. doi: 10.1016/j.cellsig.2013.08.042. Epub 2013 Sep 13.
2013
|
16 | BST2
|
| Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
|
| Sayeed A, Luciani-Torres G, Meng Z, Bennington JL, Moore DH, Dairkee SH.
|
| PLoS One 8(6):e67191. doi: 10.1371/journal.pone.0067191. Print 2013.
2013
|
17 | BST2
|
| Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
|
| Serra-Moreno R, Zimmermann K, Stern LJ, Evans DT.
|
| PLoS Pathog 9(7):e1003487. doi: 10.1371/journal.ppat.1003487. Epub 2013 Jul 11.
2013
|
18 | BST2
|
| CD317/tetherin is an organiser of membrane microdomains.
|
| Billcliff PG, Rollason R, Prior I, Owen DM, Gaus K, Banting G.
|
| J Cell Sci 126(Pt 7):1553-64. doi: 10.1242/jcs.112953. Epub 2013 Feb 1.
2013
|
19 | BST2, IL27
|
| IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN.
|
| Guzzo C, Jung M, Graveline A, Banfield BW, Gee K.
|
| Sci Rep 2:974. doi: 10.1038/srep00974. Epub 2012 Dec 13.
2012
|
20 | BST2
|
| The role of the structural domains of human BST-2 in inhibiting the release of xenotropic murine leukemia virus-related virus.
|
| Hu S, Pang X, Li J, Cen S, Jin Q, Guo F.
|
| Biochem Biophys Res Commun 428(1):17-23. doi: 10.1016/j.bbrc.2012.10.001. Epub 2012 Oct 6.
2012
|
21 | BST2
|
| The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.
|
| Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, Berlioz-Torrent C.
|
| PLoS Pathog 7(2):e1001265.
2011
|
22 | BST2
|
| Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release.
|
| Swiecki M, Scheaffer SM, Allaire M, Fremont DH, Colonna M, Brett TJ.
|
| J Biol Chem 286(4):2987-97. Epub 2010 Nov 17.
2011
|
23 | BST2
|
| IFN-γ-induced BST2 mediates monocyte adhesion to human endothelial cells.
|
| Yoo H, Park SH, Ye SK, Kim M.
|
| Cell Immunol 267(1):23-9. Epub 2010 Nov 3.
2011
|
24 | BST2
|
| Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses.
|
| Sauter D, Vogl M, Kirchhoff F.
|
| Hum Mutat 32(11):1243-5. doi: 10.1002/humu.21571. Epub 2011 Aug 11.
2011
|
25 | BST2
|
| BST-2/tetherin: a new component of the innate immune response to enveloped viruses.
|
| Evans DT, Serra-Moreno R, Singh RK, Guatelli JC.
|
| Trends Microbiol 18(9):388-96. Epub 2010 Aug 3. Review.
2010
|
26 | BST2
|
| BST-2 diminishes HIV-1 infectivity.
|
| Zhang J, Liang C.
|
| J Virol 84(23):12336-43. Epub 2010 Sep 22.
2010
|
27 | BST2
|
| Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations.
|
| Schubert HL, Zhai Q, Sandrin V, Eckert DM, Garcia-Maya M, Saul L, Sundquist WI, Steiner RA, Hill CP.
|
| Proc Natl Acad Sci U S A 107(42):17951-6. Epub 2010 Sep 29.
2010
|
28 | BST2
|
| Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
|
| Tokarev A, Skasko M, Fitzpatrick K, Guatelli J.
|
| AIDS Res Hum Retroviruses 25(12):1197-210. Review.
2009
|
29 | BST2
|
| Tetherin inhibits HIV-1 release by directly tethering virions to cells.
|
| Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD.
|
| Cell 139(3):499-511.
2009
|
30 | BST2
|
| Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
|
| Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.
|
| BMC Cancer 9:102.
2009
|
31 | BST2
|
| A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells.
|
| Rollason R, Korolchuk V, Hamilton C, Jepson M, Banting G.
|
| J Cell Biol 184(5):721-36. 2009
|
32 | BST2
|
| Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth.
|
| Ishikawa J, et al.
|
| Genomics 26 : 527-534. 1995
|